Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Maria Lozano-Rabella (15056515) (author)
Diğer Yazarlar:	Andrea Garcia-Garijo (15056518) (author), Jara Palomero (15056521) (author), Anna Yuste-Estevanez (15056524) (author), Florian Erhard (15056527) (author), Roc Farriol-Duran (15056530) (author), Juan Martín-Liberal (15056533) (author), Maria Ochoa-de-Olza (15056536) (author), Ignacio Matos (15056539) (author), Jared J. Gartner (15046103) (author), Michael Ghosh (15056542) (author), Francesc Canals (15056545) (author), August Vidal (15056548) (author), Josep Maria Piulats (15056551) (author), Xavier Matías-Guiu (15056554) (author), Irene Brana (15056557) (author), Eva Muñoz-Couselo (14957498) (author), Elena Garralda (15039090) (author), Andreas Schlosser (15056560) (author), Alena Gros (15056563) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller